4//SEC Filing
JOHNSON KENNETH ERLAND 4
Accession 0001867096-22-000010
CIK 0001867096other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:17 PM ET
Size
8.3 KB
Accession
0001867096-22-000010
Insider Transaction Report
Form 4
JOHNSON KENNETH ERLAND
See Remarks
Transactions
- Award
Common Stock
2022-01-03+75,000→ 165,865 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.
- [F2]These shares include 534 shares that were purchased on June 30, 2021 and 748 shares that were purchased on December 31, 2021 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001743774
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:17 PM ET
- Size
- 8.3 KB